Productos Medix SA de CV:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Productos Medix SA de CV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11181
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:メキシコ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Productos Medix SA de CV (Medix), formerly Laboratories Laif is a provider of research, development, manufacturing and marketing of pharmaceutical chemical products. The company’s products comprise livermade, pylopac, imidex, seronex, feprorex, MZ1, redotex, terfamex, prepram,sinestron, antalgin, biolaif and dixoal, among others. Its products are used to improve the proper functioning of the organism in patients with deficiencies caused by diseases such as diabetes, obesity, and metabolic syndrome, among others. The company’s dialicels allows more effective drug dosage. It markets its products in Mexico and abroad. Medix is headquartered in Coyoacan, Mexico.

Productos Medix SA de CV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Productos Medix SA de CV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Wamex Private Equity Invests US$32 Million In Productos Medix 10
Partnerships 11
Saniona Enters into Agreement with Productos Medix 11
Licensing Agreements 12
KVK-Tech Enters into Licensing Agreement with Productos Medix 12
Medifast Enters Into Licensing Agreement With Productos Medix 13
Medifast Enters Into Licensing Agreement With Productos Medix 14
Productos Medix SA de CV – Key Competitors 15
Productos Medix SA de CV – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Key Facts 2
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Productos Medix SA de CV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Productos Medix SA de CV, Deals By Therapy Area, 2012 to YTD 2018 8
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Wamex Private Equity Invests US$32 Million In Productos Medix 10
Saniona Enters into Agreement with Productos Medix 11
KVK-Tech Enters into Licensing Agreement with Productos Medix 12
Medifast Enters Into Licensing Agreement With Productos Medix 13
Medifast Enters Into Licensing Agreement With Productos Medix 14
Productos Medix SA de CV, Key Competitors 15

List of Figures
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Productos Medix SA de CV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Productos Medix SA de CV:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oncomatryx Biopharma SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Oncomatryx Biopharma SL (Oncomatryx) is a developer of precision drugs. The company offers precision drugs that targets proteins located in the tumor environment. It develops therapeutic antibody-drug conjugates, antibodies, and human-derived proteins, which targets tumor associated stroma. …
  • Sopheon Plc:企業の戦略・SWOT・財務情報
    Sopheon Plc - Strategy, SWOT and Corporate Finance Report Summary Sopheon Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • TransMontaigne Product Services LLC:企業の戦略的SWOT分析
    TransMontaigne Product Services LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • First Solar Inc (FSLR)-エネルギー分野:企業M&A・提携分析
    Summary First Solar, Inc. (First Solar) is a provider of photovoltaic (PV) solar energy solutions. It designs, manufactures and sells PV solar modules with an advanced thin-film semiconductor technology; and also develops, designs, constructs and sells PV solar power systems. The company uses its Cd …
  • JD Sports Fashion Plc:戦略・SWOT・企業財務分析
    JD Sports Fashion Plc - Strategy, SWOT and Corporate Finance Report Summary JD Sports Fashion Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Central Garden & Pet Co (CENT):企業の財務・戦略的SWOT分析
    Central Garden & Pet Co (CENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Biofuels Power Corp (BFLS):企業の財務・戦略的SWOT分析
    Summary Biofuels Power Corp (BFLS), is a renewable energy corporation that develops bio fuels. The corporation operates and develops grid-connected biodiesel power electric generation plants. It produces fuels through transesterification of off-spec oils and gasification of waste products such as gl …
  • Resilux NV:企業の戦略・SWOT・財務情報
    Resilux NV - Strategy, SWOT and Corporate Finance Report Summary Resilux NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Second Sight Medical Products Inc (EYES):医療機器:M&Aディール及び事業提携情報
    Summary Second Sight Medical Products Inc (Second Sight) is a medical device company that develops, manufactures and markets implantable visual prosthetics for blind individuals. The company offers Argus II retinal prosthesis system, a device that restores some functional vision for people suffering …
  • Andrew Peller Limited:企業の戦略・SWOT・財務情報
    Andrew Peller Limited - Strategy, SWOT and Corporate Finance Report Summary Andrew Peller Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Esprinet SpA (PRT):企業の財務・戦略的SWOT分析
    Esprinet SpA (PRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Mudman Public Company Limited (MM):企業の財務・戦略的SWOT分析
    Mudman Public Company Limited (MM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • ClearStream Energy Services Inc:企業の戦略・SWOT・財務情報
    ClearStream Energy Services Inc - Strategy, SWOT and Corporate Finance Report Summary ClearStream Energy Services Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • National Bank of Canada:企業の戦略・SWOT・財務情報
    National Bank of Canada - Strategy, SWOT and Corporate Finance Report Summary National Bank of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Cinemark Holdings Inc (CNK):企業の財務・戦略的SWOT分析
    Cinemark Holdings Inc (CNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Motorola Solutions, Inc.:企業の戦略・SWOT・財務情報
    Motorola Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Motorola Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • PharmaCyte Biotech Inc (PMCB):製薬・医療:M&Aディール及び事業提携情報
    Summary PharmaCyte Biotech Inc (PharmaCyte), formerly Nuvilex Inc, is a clinical stage biotechnology company that develops and commercializes treatments for cancer and diabetes. The company offers technology is used for the treatment of advanced and inoperable pancreatic cancer and diabetes. It deve …
  • Crohn’s & Colitis Foundation Inc-製薬・医療分野:企業M&A・提携分析
    Summary Crohn's & Colitis Foundation Inc (CCF) is a non-profit organization which focuses on providing treatments for crohn's disease and ulcerative colitis. The organization funds studies at medical institutions, nurture investigators, and finance underdeveloped areas of research. CCF’s partners in …
  • Topdanmark AS (TOP):企業の財務・戦略的SWOT分析
    Topdanmark AS (TOP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Michels Corp:企業の戦略・SWOT・財務情報
    Michels Corp - Strategy, SWOT and Corporate Finance Report Summary Michels Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆